We are delighted to share some highly viewed papers on pediatric oncology that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

“Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience”
by Adriana Trabal, Amber Gibson, Jiasen He, David McCall, Michael Roth, Cesar Nuñez, Miriam Garcia, Meredith Buzbee, Laurie Toepfer, Aram Bidikian et al.
Cancers 2023, 15(7), 1983; https://doi.org/10.3390/cancers15071983
Available online: https://www.mdpi.com/2072-6694/15/7/1983

“Advancing Pediatric Oncology Rehabilitation: Survey Findings of Health Professionals’ Perceptions of Barriers to Care and a Framework for Action”
by Paula A. Ospina, Lesley Pritchard, David D. Eisenstat and Margaret L. McNeely
Cancers 2023, 15(3), 693; https://doi.org/10.3390/cancers15030693
Available online: https://www.mdpi.com/2072-6694/15/3/693

“Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma”
by Silvia Pomella, Sara G. Danielli, Rita Alaggio, Willemijn B. Breunis, Ebrahem Hamed, Joanna Selfe, Marco Wachtel, Zoe S. Walters, Beat W. Schäfer, Rossella Rota et al.
Cancers 2023, 15(10), 2823; https://doi.org/10.3390/cancers15102823
Available online: https://www.mdpi.com/2072-6694/15/10/2823

“Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma”
by Yujia Chen, Chao Zhao, Shenglun Li, Jun Wang and Hongwei Zhang
Cancers 2023, 15(3), 602; https://doi.org/10.3390/cancers15030602
Available online: https://www.mdpi.com/2072-6694/15/3/602

“Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature”
by Louisa Taylor, Philippa K. Wade, James E. C. Johnson, Macha Aldighieri, Sonia Morlando, Gianpiero Di Leva, Ian D. Kerr and Beth Coyle
Cancers 2023, 15(4), 1086; https://doi.org/10.3390/cancers15041086
Available online: https://www.mdpi.com/2072-6694/15/4/1086

“Biological Role and Clinical Implications of MYOD1^L122R Mutation in Rhabdomyosarcoma”
by Daniela Di Carlo, Julia Chisholm, Anna Kelsey, Rita Alaggio, Gianni Bisogno, Veronique Minard-Colin, Meriel Jenney, Raquel Dávila Fajardo, Johannes H. M. Merks, Janet M. Shipley et al.
Cancers 2023, 15(6), 1644; https://doi.org/10.3390/cancers15061644
Available online: https://www.mdpi.com/2072-6694/15/6/1644

“Pediatric Cancer: From Molecular Targets to Effective Therapies” Edited by: Dr. Raushan Kurmasheva Submission deadline: 29 February 2024	“Pediatric and AYA Sarcoma and Intermediate Tumors” Edited by: Prof. Dr. Yoshihiro Nishida Submission deadline: 25 March 2024
“Updates on Management and Clinical Trials in Pediatric Oncology” Edited by: Dr. Atsushi Makimoto, Dr. Yasuhiro Okamoto and Dr. Yuki Yuza Submission deadline: 15 April 2024	“Challenges and New Strategies in the Management of Pediatric Brain Tumors” Edited by: Dr. Semi B. Harrabi and Prof. Dr. Adilia Hormigo Submission deadline: 31 May 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office